Inhibrx
Biotechnology

Inhibrx: Risk & public record

Inhibrx: 40 research papers in five years, 2 federal court cases.

Data updated Nov 22, 2026 · Back to the company report

What the registers and the postings say about this employer.

Legal entity active
Inhibrx, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Public record

Inhibrx: 40 research papers in five years, 2 federal court cases.

Research outputpapers its people wrote, per OpenAlex
40papers in five years
596citations
Monoclonal and Polyclonal Antibodies Research
Immunology and Microbiology
22 papers
Cancer Immunotherapy and Biomarkers
Medicine
18 papers
Immunotherapy and Immune Responses
Immunology and Microbiology
17 papers
T-cell and B-cell Immunology
Immunology and Microbiology
13 papers
Sarcoma Diagnosis and Treatment
Medicine
7 papers
Patents
Published US applications
31
US federal cases naming it as a party
Mar 2022 – Jun 2022 · 2 as defendant · 2 closed
Most common: 880 Defend Trade Secrets Act (of 2016) 1
2
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.